0:00
3:48
Jim and Jeff discuss Eli Lilly after the company beat on quarterly profit and hiked its full-year guidance on strong sales of Mounjaro and Zepbound. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake
CNBC Investing Club Disclaimer
D'autres épisodes de "Squawk on the Street"
Ne ratez aucun épisode de “Squawk on the Street” et abonnez-vous gratuitement à ce podcast dans l'application GetPodcast.